Back to Top
Go Back
Journal Photo for Journal of the American Heart Association
Peer reviewed only Open Access

Journal of the American Heart Association (JAHA)

Publisher : American Heart Association Inc.
Cardiology Cardiovascular Medicine
Claim Your Journal Get PRC Visit Website
e-ISSN 2047-9980
Issue Frequency Bi-Monthly
Impact Factor 5.0
Est. Year 2012
Mobile 8002428721
DOI YES
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email jaha@journalaha.org

Journal Descriptions

The Journal of the American Heart Association (JAHA): Cardiovascular and Cerebrovascular Disease is an international, peer-reviewed, open access, scientific journal that publishes all types of original research articles, including studies conducted with human subjects and experimental models, as well as applied clinical, epidemiological, and healthcare policy papers related to cardiovascular and cerebrovascular diseases. Our mission is to assist the science, scientist, and society in creating a world of longer, healthier lives. Our vision is to innovate and incorporate promising technologies to communicate freely-available, high-priority, high-quality content, which accelerates scientific progress and advances heart and brain health. We value integrity, excellence and inclusiveness. JAHA is an official journal of the American Heart Association and seeks to be the leading open access scientific journal with a cardiovascular and cerebrovascular disease remit in the world.

Journal of the American Heart Association (JAHA) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Cardiology, Cardiovascular Medicine , Online , Bi-Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2047-9980, Established: 2012, Impact Factor: 5.0
  • Provides Crossref DOI

  • Indexed in: DOAJ

  • Not indexed in Scopus, WoS, PubMed, UGC CARE

Indexing

Publications of JAHA

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis
Peter B Jones April, 2016
Background Host factors and complications have been associated with higher mortality in infective endocarditis (IE). We sought to develop and validate a model of clinical characteristics to...
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association
Stephen Sidney September, 2017
Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions t...
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER S...
C. Noel Bairey Merz March, 2016
Background The majority of women with angina‐like chest pain have no obstructive coronary artery disease when evaluated with coronary angiography. Coronary microvascular dysfunction is a ...
Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
C. Noel Bairey Merz August, 2018
An increasing number of stable patients with evidence of ischemia but no obstructive coronary artery disease (CAD) at coronary angiography, now termed INOCA, are seen. Objective myocardial i...
Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years Postpartum
Philip Greenland September, 2019
Background Identifying pregnancy‐associated risk factors before the development of major cardiovascular disease events could provide opportunities for prevention. The objective of this st...
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Sy...
C. Noel Bairey Merz June, 2019
Background Previous studies have reported an association between the timing of menarche and cardiovascular disease (CVD). However, emerging studies have not examined the timing of menarche ...
Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored ...
C. Noel Bairey Merz February, 2014
Background Women are more likely than men to develop resistant hypertension, which is associated with excess risk of major adverse outcomes; however, the impact of resistant hypertension in...
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Jeremy Neil Ruskin September, 2019
Although the number of Americans dying of cardiovascular disease (CVD) continues to increase since 2010 after decades of decrease, advances in the management of CVD have led to increased lon...
Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium
Emelia J. Benjamin March, 2013
Background Tools for the prediction of atrial fibrillation (AF) may identify high‐risk individuals more likely to benefit from preventive interventions and serve as a benchmark to test no...
Blood Lipids and the Incidence of Atrial Fibrillation: The Multi‐Ethnic Study of Atherosclerosis and the Framingham Heart Study
Emelia J. Benjamin October, 2014
Background Dyslipidemia is a major contributor to the development of atherosclerosis and coronary disease. Its role in the etiology of atrial fibrillation (AF) is uncertain. Methods and Re...